ANXA1 inhibits cellular autophagy and promotes tumour invasion and metastasis through PI3K/AKT signalling activation in nasopharyngeal carcinoma (Zhu et al., 2018). Here, ANXA1 is linked to nasopharyngeal carcinoma.